ID   ROR1_HUMAN              Reviewed;         937 AA.
AC   Q01973; Q5VVX6; Q92776;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   02-NOV-2010, entry version 112.
DE   RecName: Full=Tyrosine-protein kinase transmembrane receptor ROR1;
DE            EC=2.7.10.1;
DE   AltName: Full=Neurotrophic tyrosine kinase, receptor-related 1;
DE   Flags: Precursor;
GN   Name=ROR1; Synonyms=NTRKR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), AND VARIANT MET-518.
RX   MEDLINE=93100347; PubMed=1334494;
RA   Masiakowski P., Carroll R.D.;
RT   "A novel family of cell surface receptors with tyrosine kinase-like
RT   domain.";
RL   J. Biol. Chem. 267:26181-26190(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RX   MEDLINE=97030043; PubMed=8875995;
RA   Reddy U.R., Phatak S., Pleasure D.;
RT   "Human neural tissues express a truncated Ror1 receptor tyrosine
RT   kinase, lacking both extracellular and transmembrane domains.";
RL   Oncogene 13:1555-1559(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-562.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-144; LEU-150; VAL-301; MET-518;
RP   ILE-567; ARG-624; CYS-646 AND ASN-776.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Tyrosine-protein kinase receptor whose role is not yet
CC       clear.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q01973-1; Sequence=Displayed;
CC       Name=Short; Synonyms=T-ROR1;
CC         IsoId=Q01973-2; Sequence=VSP_005008;
CC   -!- TISSUE SPECIFICITY: Expressed strongly in human heart, lung and
CC       kidney, but weakly in the CNS. Isoform Short is strongly expressed
CC       in fetal and adult CNS and in a variety of human cancers,
CC       including those originating from CNS or PNS neuroectoderm.
CC   -!- DEVELOPMENTAL STAGE: Expressed at high levels during early
CC       embryonic development. The expression levels drop strongly around
CC       day 16 and there are only very low levels in adult tissues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. ROR subfamily.
CC   -!- SIMILARITY: Contains 1 FZ (frizzled) domain.
CC   -!- SIMILARITY: Contains 1 Ig-like C2-type (immunoglobulin-like)
CC       domain.
CC   -!- SIMILARITY: Contains 1 kringle domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M97675; AAA60275.1; -; mRNA.
DR   EMBL; U38894; AAC50714.1; -; mRNA.
DR   EMBL; AL445205; CAH71706.1; -; Genomic_DNA.
DR   EMBL; AL137859; CAH71706.1; JOINED; Genomic_DNA.
DR   EMBL; AL161742; CAH71706.1; JOINED; Genomic_DNA.
DR   EMBL; AL137859; CAI21732.1; -; Genomic_DNA.
DR   EMBL; AL445205; CAI21732.1; JOINED; Genomic_DNA.
DR   EMBL; AL161742; CAI21732.1; JOINED; Genomic_DNA.
DR   EMBL; AL161742; CAI21932.1; -; Genomic_DNA.
DR   EMBL; AL445205; CAI21932.1; JOINED; Genomic_DNA.
DR   EMBL; AL137859; CAI21932.1; JOINED; Genomic_DNA.
DR   IPI; IPI00010405; -.
DR   IPI; IPI00472950; -.
DR   PIR; A45082; A45082.
DR   RefSeq; NP_005003.2; -.
DR   UniGene; Hs.654491; -.
DR   ProteinModelPortal; Q01973; -.
DR   SMR; Q01973; 61-149, 311-393, 466-749.
DR   DIP; DIP-29734N; -.
DR   DIP; DIP-5713N; -.
DR   STRING; Q01973; -.
DR   PhosphoSite; Q01973; -.
DR   PRIDE; Q01973; -.
DR   Ensembl; ENST00000371079; ENSP00000360120; ENSG00000185483.
DR   GeneID; 4919; -.
DR   UCSC; uc001dbj.2; human.
DR   CTD; 4919; -.
DR   GeneCards; GC01P064171; -.
DR   HGNC; HGNC:10256; ROR1.
DR   MIM; 602336; gene.
DR   PharmGKB; PA34628; -.
DR   HOVERGEN; HBG017736; -.
DR   InParanoid; Q01973; -.
DR   OMA; KRQLLPC; -.
DR   OrthoDB; EOG9WDGX5; -.
DR   PhylomeDB; Q01973; -.
DR   BRENDA; 2.7.10.1; 247.
DR   NextBio; 18939; -.
DR   ArrayExpress; Q01973; -.
DR   Bgee; Q01973; -.
DR   CleanEx; HS_ROR1; -.
DR   Genevestigator; Q01973; -.
DR   GermOnline; ENSG00000185483; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   GO; GO:0017147; F:Wnt-protein binding; IPI:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR016247; Tyr_kinase_rcpt_ROR_subgr.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020763; Tyr_prot_kinase_rcpt_ROR.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1.
DR   Gene3D; G3DSA:2.40.20.10; Kringle; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF275; Tyr_prot_kinase_rcpt_ROR; 1.
DR   Pfam; PF01392; Fz; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00051; Kringle; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF000624; TyrPK_TMrec_ROR; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00130; KR; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF57440; Kringle-like; 1.
DR   PROSITE; PS50038; FZ; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Complete proteome; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Kinase; Kringle; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor; Signal;
KW   Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     29       Potential.
FT   CHAIN        30    937       Tyrosine-protein kinase transmembrane
FT                                receptor ROR1.
FT                                /FTId=PRO_0000024458.
FT   TOPO_DOM     30    406       Extracellular (Potential).
FT   TRANSMEM    407    427       Helical; (Potential).
FT   TOPO_DOM    428    937       Cytoplasmic (Potential).
FT   DOMAIN       42    147       Ig-like C2-type.
FT   DOMAIN      165    299       FZ.
FT   DOMAIN      312    391       Kringle.
FT   DOMAIN      473    746       Protein kinase.
FT   NP_BIND     479    487       ATP (By similarity).
FT   COMPBIAS    753    782       Ser/Thr-rich.
FT   COMPBIAS    784    851       Pro-rich.
FT   COMPBIAS    853    876       Ser/Thr-rich.
FT   ACT_SITE    615    615       Proton acceptor (By similarity).
FT   BINDING     506    506       ATP (By similarity).
FT   MOD_RES     645    645       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD     47     47       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     66     66       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    184    184       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    315    315       N-linked (GlcNAc...) (Potential).
FT   DISULFID     79    131       By similarity.
FT   DISULFID    170    235       By similarity.
FT   DISULFID    178    228       By similarity.
FT   DISULFID    219    260       By similarity.
FT   DISULFID    248    296       By similarity.
FT   DISULFID    252    282       By similarity.
FT   DISULFID    313    391       By similarity.
FT   DISULFID    334    374       By similarity.
FT   DISULFID    362    386       By similarity.
FT   VAR_SEQ       1    549       Missing (in isoform Short).
FT                                /FTId=VSP_005008.
FT   VARIANT     144    144       G -> E (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041779.
FT   VARIANT     150    150       F -> L (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041780.
FT   VARIANT     301    301       I -> V (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041781.
FT   VARIANT     518    518       T -> M (in dbSNP:rs7527017).
FT                                /FTId=VAR_041782.
FT   VARIANT     562    562       E -> D (in a breast cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035713.
FT   VARIANT     567    567       R -> I (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041783.
FT   VARIANT     624    624       G -> R (in dbSNP:rs55832740).
FT                                /FTId=VAR_041784.
FT   VARIANT     646    646       Y -> C (in dbSNP:rs34109134).
FT                                /FTId=VAR_041785.
FT   VARIANT     776    776       S -> N (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041786.
SQ   SEQUENCE   937 AA;  104283 MW;  0EC0E4762A90C6C7 CRC64;
     MHRPRRRGTR PPLLALLAAL LLAARGAAAQ ETELSVSAEL VPTSSWNISS ELNKDSYLTL
     DEPMNNITTS LGQTAELHCK VSGNPPPTIR WFKNDAPVVQ EPRRLSFRST IYGSRLRIRN
     LDTTDTGYFQ CVATNGKEVV SSTGVLFVKF GPPPTASPGY SDEYEEDGFC QPYRGIACAR
     FIGNRTVYME SLHMQGEIEN QITAAFTMIG TSSHLSDKCS QFAIPSLCHY AFPYCDETSS
     VPKPRDLCRD ECEILENVLC QTEYIFARSN PMILMRLKLP NCEDLPQPES PEAANCIRIG
     IPMADPINKN HKCYNSTGVD YRGTVSVTKS GRQCQPWNSQ YPHTHTFTAL RFPELNGGHS
     YCRNPGNQKE APWCFTLDEN FKSDLCDIPA CDSKDSKEKN KMEILYILVP SVAIPLAIAL
     LFFFICVCRN NQKSSSAPVQ RQPKHVRGQN VEMSMLNAYK PKSKAKELPL SAVRFMEELG
     ECAFGKIYKG HLYLPGMDHA QLVAIKTLKD YNNPQQWTEF QQEASLMAEL HHPNIVCLLG
     AVTQEQPVCM LFEYINQGDL HEFLIMRSPH SDVGCSSDED GTVKSSLDHG DFLHIAIQIA
     AGMEYLSSHF FVHKDLAARN ILIGEQLHVK ISDLGLSREI YSADYYRVQS KSLLPIRWMP
     PEAIMYGKFS SDSDIWSFGV VLWEIFSFGL QPYYGFSNQE VIEMVRKRQL LPCSEDCPPR
     MYSLMTECWN EIPSRRPRFK DIHVRLRSWE GLSSHTSSTT PSGGNATTQT TSLSASPVSN
     LSNPRYPNYM FPSQGITPQG QIAGFIGPPI PQNQRFIPIN GYPIPPGYAA FPAAHYQPTG
     PPRVIQHCPP PKSRSPSSAS GSTSTGHVTS LPSSGSNQEA NIPLLPHMSI PNHPGGMGIT
     VFGNKSQKPY KIDSKQASLL GDANIHGHTE SMISAEL
//
